Irritable bowel syndrome

Last updated: June 24, 2022

Summarytoggle arrow icon

Irritable bowel syndrome (IBS) is a common chronic condition affecting 20–50% of patients with gastrointestinal complaints. The exact pathophysiology is unknown, but may involve changes in gastrointestinal motility, visceral hypersensitivity, and altered gastrointestinal permeability. The condition presents with recurrent, non‑specific changes in bowel movements (e.g., diarrhea and/or constipation) and abdominal symptoms (e.g., diffuse pain, pressure). The Rome IV diagnostic criteria, which are based on alterations in bowel habits, are used to diagnose IBS. Laboratory studies and imaging reveal no abnormalities. Treatment consists of dietary modifications and administration of symptom‑based medication (antidiarrheals, laxatives, antispasmodics).

  • Prevalence: 10–20% in North America and Europe (accounts for 20–50% of referrals to gastroenterologists)
  • Sex: : In Western countries, women are 1.5–2 times more likely to be affected than men.
  • Age: highest prevalence in individuals aged 20–39 [1]


Epidemiological data refers to the US, unless otherwise specified.

IBS is a functional gastrointestinal disorder without a specific organic cause. The pathophysiological processes leading to IBS are multifaceted and not yet fully understood. The most common findings associated with IBS are:

  • Altered gastrointestinal motility
  • Visceral hypersensitivity/hyperalgesia
  • Altered permeability of the gastrointestinal mucosa
  • Psychosocial aspects


IBS is characterized by chronic abdominal pain and changes in bowel habits – both of which are typical, but not specific, symptoms of the condition.

Red flag symptoms: nighttime diarrhea and abdominal pain, fever, bloody stools, weight loss, and acute onset of symptoms!

Four different patterns are seen in the presentation of irritable bowel syndrome:

IBS is a clinical diagnosis; based on the patient's history (Rome IV criteria) and symptoms. However, any suspected differential diagnoses should be ruled out before making a definitive diagnosis.

Patient history

  • Rome IV criteria for irritable bowel syndrome: diagnosis can be made if the following criteria are present
    • Recurrent abdominal pain on average at least 1 day per week during the previous 3 months that is associated with 2 or more of the following:
      • Pain related to defecation
      • Change in stool frequency
      • Change in stool form or appearance
  • Other symptoms consistent with IBS (see "Symptoms/clinical findings")
  • A family history of inflammatory bowel disease, celiac disease, or colorectal cancer is unusual in patients with IBS.

Ruling out organic disease

If no other differential diagnosis is suspected, laboratory tests and imaging are generally not recommended for individuals under the age of 50 if they show typical signs of IBS and lack any alarming signs, such as iron-deficiency anemia, weight loss, or a family history of organic gastrointestinal diseases.


Overview of common differential diagnoses
Condition General appearance Pain Stool habits
Irritable bowel syndrome
  • Healthy; no weight loss
  • Alleviated by defecation; diffuse; no nighttime pain
Crohn disease
  • Usually constant; occurs particularly in the right lower abdomen; may appear at night
Ulcerative colitis
  • Weight loss only in severe cases
  • Mostly left lower abdomen; may occur at night
Colorectal carcinoma
  • Weight loss

Other differential diagnoses to consider

The differential diagnoses listed here are not exhaustive.

General measures

  • Regular consultations and reassurance that the disease, although chronic, is benign
  • Lifestyle changes
    • Dietary adjustments
      • Plenty of fluid
      • High‑fiber foods
      • Avoidance of:
        • Gas‑producing foods (e.g., beans, onions, prunes)
        • Fermentable, short‑chain carbohydrates (e.g., foods with high fructose content: honey, apples, corn syrup)
        • Lactose
        • Gluten
    • Physical activity
    • Stress management (identification of stress factors, avoidance techniques, relaxation therapy)
  • Psychological therapy (patients with psychological conditions): e.g., cognitive-behavioral therapy

Medical therapy

Medical therapy of IBS is symptom‑directed:

  1. Wilkins T, Pepitone C, Alex B, Schade RR. Diagnosis and management of IBS in adults. Am Fam Physician. 2012; 86 (5): p.419-426.
  2. Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol. 2014; 6 : p.71-80. doi: 10.2147/CLEP.S40245 . | Open in Read by QxMD
  3. Camilleri M, Lasch K, Zhou W. Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. American Journal of Physiology. 2012; 303 (7): p.775-785. doi: 10.1152/ajpgi.00155.2012 . | Open in Read by QxMD
  4. Thabane M, Marshall JK. Post-infectious irritable bowel syndrome. World J Gastroenterol. 2009; 15 (29): p.3591-3596.
  5. Spiegel BMR, Farid M, Esrailian E, Talley J, Chang L. Is Irritable Bowel Syndrome a Diagnosis of Exclusion?: A Survey of Primary Care Providers, Gastroenterologists, and IBS Experts. Am J Gastroenterol. 2010; 105 (4): p.848-858. doi: 10.1038/ajg.2010.47 . | Open in Read by QxMD
  6. Mayer EA, Bradesi S. Alosetron and irritable bowel syndrome. Expert Opin Pharmacother. 2003; 4 (11): p.2089-2098. doi: 10.1517/14656566.4.11.2089 . | Open in Read by QxMD

3 free articles remaining

You have 3 free member-only articles left this month. Sign up and get unlimited access.
 Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer